MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2011-06-28 for COBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST 20757497122 manufactured by Roche Molecular Systems.
[2117023]
A customer site in (b)(6) alleged that false (b)(6) results were generated during a comparison study with the cobas amplicor chlamydia trachomatis test. (b)(4) they ran previously run (b)(6) samples on three of their instruments and one of the instruments - (b)(4)- generated discrepant results. The samples had been stored at 2-8 degrees for one day then were frozen at -20 degrees.
Patient Sequence No: 1, Text Type: D, B5
[9153549]
A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of the investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10
[9219471]
(b)(4). No failure detected and product within specification. Urine samples from two patients previously generated (b)(4) ct results. Upon retesting for a comparison study, (b)(4) results were obtained for some replicates. The samples had been stored at 2-8c for one day and then were frozen at -20c. The customer reported that the patients whose samples produced the discrepant results were not adversely affected. The customer was not willing to provide any further information for the investigation, including kit lot numbers or laboratory statistics (b)(4). No patient samples were provided for investigative testing. Based on the limited available information, no product non-conformance was identified. (b)(4). It is also noted that the sensitivity was lower for frozen male urine specimens and higher for frozen female urine specimens, as compared to specimens which had not been frozen. It is unknown whether the two samples which generated discrepant results were male or female. The customer did not provide any statistics that could be used to determine if the discrepant results generated were within product labeling claims. (b)(4).
Patient Sequence No: 1, Text Type: N, H10
Report Number | 2243471-2011-00069 |
MDR Report Key | 2142254 |
Report Source | 05 |
Date Received | 2011-06-28 |
Date of Report | 2011-06-01 |
Date of Event | 2011-03-15 |
Date Mfgr Received | 2011-06-01 |
Date Added to Maude | 2012-02-13 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 0 |
Event Location | 0 |
Manufacturer Contact | VINCENT STAGNITTO |
Manufacturer Street | 1080 US HWY 202S |
Manufacturer City | BRANCHBURG NJ 088763733 |
Manufacturer Country | US |
Manufacturer Postal | 088763733 |
Manufacturer Phone | 9082537569 |
Single Use | 0 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | COBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST |
Generic Name | DNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA |
Product Code | MKZ |
Date Received | 2011-06-28 |
Catalog Number | 20757497122 |
Device Availability | N |
Device Age | DA |
Device Eval'ed by Mfgr | Y |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | ROCHE MOLECULAR SYSTEMS |
Manufacturer Address | 1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 2011-06-28 |